Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 1
2006 2
2007 1
2009 1
2010 7
2011 3
2012 1
2013 4
2014 3
2015 6
2016 11
2017 5
2018 5
2019 12
2020 8
2021 12
2022 14
2023 14
2024 8
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

112 results

Results by year

Filters applied: . Clear all
Page 1
Effect of different PD-1 inhibitor combination therapies for unresectable intrahepatic cholangiocarcinoma.
Lei Z, Ma W, Si A, Zhang Y, Yang F, Yu Q, Tang H, Xiao Q, Zhou J, Wang K, Tang Y, Han T, Yin G, Chen J, Liu X, Zhao H, Yu D, Luo T, Wang Q, Yan M, Mao X, Li J, Wang K, Li J, Zeng Y, Ding D, Chen T, Wu X, Xia Y, Wang K, Guo W, Zhu G, Gao S, Hüser N, Lau WY, Song T, Cheng S, Shen F, Cheng Z. Lei Z, et al. Among authors: guo w. Aliment Pharmacol Ther. 2023 Sep;58(6):611-622. doi: 10.1111/apt.17623. Epub 2023 Jun 22. Aliment Pharmacol Ther. 2023. PMID: 37349908
Chinese Expert Consensus on the Whole-Course Management of Hepatocellular Carcinoma (2023 Edition).
Yang Y, Sun J, Cai J, Chen M, Dai C, Wen T, Xia J, Ying M, Zhang Z, Zhang X, Fang C, Shen F, An P, Cai Q, Cao J, Zeng Z, Chen G, Chen J, Chen P, Chen Y, Shan Y, Dang S, Guo WX, He J, Hu H, Huang B, Jia W, Jiang K, Jin Y, Jin Y, Jin Y, Li G, Liang Y, Liu E, Liu H, Peng W, Peng Z, Peng Z, Qian Y, Ren W, Shi J, Song Y, Tao M, Tie J, Wan X, Wang B, Wang J, Wang K, Wang K, Wang X, Wei W, Wu FX, Xiang B, Xie L, Xu J, Yan ML, Ye Y, Yue J, Zhang X, Zhang Y, Zhang A, Zhao H, Zhao W, Zheng X, Zhou H, Zhou H, Zhou J, Zhou X, Cheng SQ, Li Q; Chinese Association of Liver Cancer and Chinese Medical Doctor Association. Yang Y, et al. Liver Cancer. 2024 Oct 22;14(3):311-333. doi: 10.1159/000541622. eCollection 2025 Jun. Liver Cancer. 2024. PMID: 40547957 Free PMC article. Review.
Transarterial chemoembolization plus atezolizumab and bevacizumab in patients with intermediate hepatocellular carcinoma: a single-arm, phase 2 trial.
Wang K, Feng J, Yu H, Cheng Y, Xiang Y, Liu Z, Qin Y, Liu E, Shan Y, Fan C, Zhai J, He D, Zhou H, Tang Y, Shi J, Guo W, Yan M, Yu L, Kudo M, Cheng S. Wang K, et al. Among authors: guo w. Signal Transduct Target Ther. 2025 Oct 6;10(1):328. doi: 10.1038/s41392-025-02427-0. Signal Transduct Target Ther. 2025. PMID: 41047409 Free PMC article. Clinical Trial.
112 results